ConductScience.org, home

Paper36733464

Breast Cancer Management in the Era of Covid-19; Key Issues, Contemporary Strategies, and Future Implications.

Prodhan AHMSU and 11 others. Breast Cancer (Dove Med Press), 2023. Cited by 17 papers, by iCite.

Cite this record

ConductScience Library. Breast Cancer Management in the Era of Covid-19; Key Issues, Contemporary Strategies, and Future Implications. Papers, record 36733464. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/36733464

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Breast Cancer Management in the Era of Covid-19; Key Issues, Contemporary Strategies, and Future Implications.
PubMed
Journal
Breast Cancer (Dove Med Press)
PubMed
Year
2023
PubMed
Publication types
Journal Article, Review
PubMed
Citations, by iCite
17
iCite
Relative citation ratio, by iCite
2.35
iCite
Revised in PubMed
2023-02-04
PubMed

Authors12

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Prodhan AHMSUA H M Safayet Ullahhttps://orcid.org/0000-0002-9451-2669
2Islam DZDewan Zubaerhttps://orcid.org/0000-0003-0023-1733
3Khandker SSShahad Saifhttps://orcid.org/0000-0003-4724-0645
4Jamiruddin MRMohd Raeedhttps://orcid.org/0000-0003-0495-4808
5Abdullah AAdnanhttps://orcid.org/0000-0003-4323-7617
6Godman BBrianhttps://orcid.org/0000-0001-6539-6972
7Opanga SSylvia
8Kumar SSantoshhttps://orcid.org/0000-0002-5117-7872
9Sharma PParashttps://orcid.org/0000-0003-0107-2666
10Adnan NNihadhttps://orcid.org/0000-0002-4999-4793
11Pisana AAlice
12Haque MMainulhttps://orcid.org/0000-0002-6124-7993

Source PubMed

Download CSV of authors

Topics0

NLM's MeSH indexing of the paper, its major topics first.

None in this release.

References115

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
132550266Evidence-based guidelines for managing patients with primary ER+ HER2- breast cancer deferred from surgery due to the COVID-19 pandemic.NPJ Breast Cancer2020https://conductscience.org/library/papers/32550266PubMed
234131559Management of bone metastasis and cancer treatment-induced bone loss during the COVID-19 pandemic: An international perspective and recommendations.J Bone Oncol2021https://conductscience.org/library/papers/34131559PubMed
335426582Decreased numbers of gastric, colorectal, lung, and breast cancer surgeries performed in 17 cancer-designated hospitals in Gunma Prefecture of Japan during the COVID-19 pandemic.Surg Today2022https://conductscience.org/library/papers/35426582PubMed
433547514COVID-19 Pandemic: Changes in Care for a Community Academic Breast Center and Patient Perception of Those Changes.Ann Surg Oncol2021https://conductscience.org/library/papers/33547514PubMed
534125350Effectiveness of a Short Duration of Neoadjuvant Endocrine Therapy in Patients with HR+ Breast Cancer-An NCDB Analysis (2004-2016).Ann Surg Oncol2021https://conductscience.org/library/papers/34125350PubMed
634431019Analysis of the Impact of the COVID-19 Pandemic on the Multidisciplinary Management of Breast Cancer: Review from the American Society of Breast Surgeons COVID-19 and Mastery Registries.Ann Surg Oncol2021https://conductscience.org/library/papers/34431019PubMed
732749697Breast imaging, breast surgery, and cancer genetics in the age of COVID-19.Cancer2020https://conductscience.org/library/papers/32749697PubMed
832802693Breast Reconstruction in a Coronavirus Disease 2019 Hub.Plast Reconstr Surg Glob Open2020https://conductscience.org/library/papers/32802693PubMed
933015560Turkish national consensus on breast cancer management during temporary state of emergency due to COVID-19 outbreak.Turk J Surg2020https://conductscience.org/library/papers/33015560PubMed
1033582382Two-month stop in mammographic screening significantly impacts on breast cancer stage at diagnosis and upfront treatment in the COVID era.ESMO Open2021https://conductscience.org/library/papers/33582382PubMed
1135312952Impact of the COVID-19 Pandemic on Breast Cancer Management in Portugal: A Cross-Sectional Survey-Based Study of Medical Oncologists.Oncol Ther2022https://conductscience.org/library/papers/35312952PubMed
1232437662Early impact of the COVID-19 pandemic on paediatric cancer care in Latin America.Lancet Oncol2020https://conductscience.org/library/papers/32437662PubMed
1332191691Evaluation of the Effectiveness of Surveillance and Containment Measures for the First 100 Patients with COVID-19 in Singapore - January 2-February 29, 2020.MMWR Morb Mortal Wkly Rep2020https://conductscience.org/library/papers/32191691PubMed
1433469376Patients' Responses to the Sudden Interruption of Chemotherapy During the Outbreak of the Novel Coronavirus: A Cross-Sectional Study.Cancer Manag Res2021https://conductscience.org/library/papers/33469376PubMed
1532241520International Guidelines on Radiation Therapy for Breast Cancer During the COVID-19 Pandemic.Clin Oncol (R Coll Radiol)2020https://conductscience.org/library/papers/32241520PubMed
1630867655Cost effectiveness and affordability of trastuzumab in sub-Saharan Africa for early stage HER2-positive breast cancer.Cost Eff Resour Alloc2019https://conductscience.org/library/papers/30867655PubMed
1732594966Healthcare utilization among breast cancer patients during the COVID-19 outbreak.Palliat Support Care2020https://conductscience.org/library/papers/32594966PubMed
1834170430Cancer in the Shadow of COVID: Early-Stage Breast and Prostate Cancer Patient Perspectives on Surgical Delays Due to COVID-19.Ann Surg Oncol2021https://conductscience.org/library/papers/34170430PubMed
1932665948Global burden of COVID-19 pandemic on healthcare workers.ERJ Open Res2020https://conductscience.org/library/papers/32665948PubMed
2032989430Suboptimal declines and delays in early breast cancer treatment after COVID-19 quarantine restrictions in China: A national survey of 8397 patients in the first quarter of 2020.EClinicalMedicine2020https://conductscience.org/library/papers/32989430PubMed

See all 115 referencesDownload CSV of references

Cited by13

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 17 citations.

PMIDTitleJournalYearIn PapersSource
41915268The impact of the COVID-19 pandemic on breast cancer screening, treatment, and overall survival.Breast Cancer Res Treat2026https://conductscience.org/library/papers/41915268PubMed
41517591Surgical Timing and Safety of Breast Cancer Operations After COVID-19: A Prospective-Only Meta-Analysis of Cohort Studies.J Clin Med2026https://conductscience.org/library/papers/41517591PubMed
40075655Radiogenomic Landscape of Metastatic Endocrine-Positive Breast Cancer Resistant to Aromatase Inhibitors.Cancers (Basel)2025https://conductscience.org/library/papers/40075655PubMed
40045572Differences in Age, Stage and Biology of Breast Cancer Presentations at A Private Breast Unit in Johannesburg Before and During The COVID-19 Pandemic.Eur J Breast Health2025https://conductscience.org/library/papers/40045572PubMed
39498425Strategies to Overcome Erroneous Outcomes in Reverse Transcription-Polymerase Chain Reaction (RT-PCR) Testing: Insights From the COVID-19 Pandemic.Cureus2024https://conductscience.org/library/papers/39498425PubMed
39463375The molecular anti-metastatic potential of CBD and THC from Lebanese Cannabis via apoptosis induction and alterations in autophagy.Sci Rep2024https://conductscience.org/library/papers/39463375PubMed
38832300Collateral effects of the COVID-19 pandemic on endocrine treatments for breast and prostate cancer in the UK: a cohort study.Ther Adv Med Oncol2024https://conductscience.org/library/papers/38832300PubMed
38192402Resumption of Intravenous Anti-Cancer Therapy in Breast Cancer: A Real-World Experience During the SARS-CoV-2 Pandemic.Cancer Manag Res2024https://conductscience.org/library/papers/38192402PubMed
38089948The Disruptive Impact of COVID-19 on the Utilization of Cancer Chemotherapy-Related Healthcare Assistance at the Principal Nationwide Referral Hospital in Kenya.Cureus2023https://conductscience.org/library/papers/38089948PubMed
37909210Impact of the COVID-19 pandemic on clinical presentation, treatments, and outcomes of new breast cancer patients: A retrospective multicenter cohort study.Cancer Med2023https://conductscience.org/library/papers/37909210PubMed
37631918COVID-19 Vaccine Acceptance and Hesitancy among Healthcare Workers in Lusaka, Zambia; Findings and Implications for the Future.Vaccines (Basel)2023https://conductscience.org/library/papers/37631918PubMed
37109491A Global Review of the Impacts of the Coronavirus (COVID-19) Pandemic on Radiology Practice, Finances, and Operations.Life (Basel)2023https://conductscience.org/library/papers/37109491PubMed
37108025Impact of Lockdown Measures on Health Outcomes of Adults with Type 2 Diabetes Mellitus in Bangladesh.Healthcare (Basel)2023https://conductscience.org/library/papers/37108025PubMed

Download CSV of cited by

Genes8

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

Download CSV of genes

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/36733464

GET https://conductscience.org/api/papers/v1/36733464/references?page=2